T. Rowe Price China Evolution Equity benefits from a capable portfolio manager and a differentiated investment approach that effectively draws on the manager’s domain expertise in China’s underowned smaller-cap universe. However, concerns around the supporting team’s stability and depth temper our conviction. The strategy earns an Average People rating and an Above Average Process rating.
T. Rowe Price China Evolution Equity Fund TCELX
- NAV / 1-Day Return $15.80 / +1.22 %
- Fund Size $88.5M
- Adjusted Expense Ratio 1.400%
- Net Expense Ratio 1.400%
- Fee Level: Distribution High
- Share Class Type No Load
- Morningstar Category Greater China Region
- Equity Style Box (Funds) Large Growth
- Minimum Initial Investment $2,500
- Investment Status Open
- TTM Yield 0.91%
- Turnover Ratio 104%
Morningstar’s Analysis TCELX
Will TCELX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 24.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Unimicron Technology Corp | 5.07 | 5M | Technology |
T. Rowe Price Gov. Reserve | 2.63 | 3M | Cash and Equivalents |
Shengyi Technology | 2.45 | 3M | — |
Genscript Biotech Corp Class H | 2.40 | 2M | Healthcare |
Kanzhun Ltd ADR | 2.23 | 2M | Communication Services |
Wus Printed Circuit (Kunshan) Co Ltd Class A | 2.21 | 2M | Technology |
TCL Technology Group Corp Class A | 2.14 | 2M | Technology |
H World Group Ltd Ordinary Shares | 2.11 | 2M | Consumer Cyclical |
Hongfa Technology Co Ltd Class A | 2.11 | 2M | Industrials |
United Integrated Services Co Ltd | 2.08 | 2M | Industrials |